Senate Health Committee Approves FDA Nominee

Chairman Lamar Alexander (R-Tenn.) made the following statement on the Senate health committee’s approval of Dr. Robert Califf to head the Food and Drug Administration (FDA)

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Chairman Lamar Alexander (R-Tenn.) made the following statement on the Senate health committee’s approval of Dr. Robert Califf to head the Food and Drug Administration (FDA):

“The FDA affects the lives of nearly every single American and regulates about a quarter of all consumer spending in the United States—over $4 trillion annually. Americans need competent leadership to head this significant agency and to help bring safe drugs and devices to market faster and protect our nation’s food supply. The Senate should consider Dr. Califf’s nomination quickly to fill this important role.”
The Senate health committee held a hearing on Nov. 17 to consider Dr. Califf’s nomination. Click here for Chairman Alexander’s remarks at that hearing.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO